Scientific Reports (Oct 2022)

Development and cross-national investigation of a model explaining participation in WHO-recommended and placebo behaviours to prevent COVID-19 infection

  • Joanna Kłosowska,
  • Elżbieta A. Bajcar,
  • Helena Bieniek,
  • Justyna Brączyk,
  • Mohsen Joshanloo,
  • Katia Mattarozzi,
  • Arianna Bagnis,
  • Moa Pontén,
  • Maria Lalouni,
  • Andrew L. Geers,
  • Kelly S. Clemens,
  • Joonha Park,
  • Gahee Choi,
  • Yun-Kyeung Choi,
  • Wookyoung Jung,
  • Eunjung Son,
  • Hyae Young Yoon,
  • Przemysław Bąbel

DOI
https://doi.org/10.1038/s41598-022-17303-y
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 16

Abstract

Read online

Abstract To protect themselves from COVID-19, people follow the recommendations of the authorities, but they also resort to placebos. To stop the virus, it is important to understand the factors underlying both types of preventive behaviour. This study examined whether our model (developed based on the Health Belief Model and the Transactional Model of Stress) can explain participation in WHO-recommended and placebo actions during the pandemic. Model was tested on a sample of 3346 participants from Italy, Japan, Poland, Korea, Sweden, and the US. It was broadly supported: objective risk and cues to action showed both direct and indirect (through perceived threat) associations with preventive behaviours. Moreover, locus of control, decision balance, health anxiety and preventive coping moderated these relationships. Numerous differences were also found between countries. We conclude that beliefs about control over health and perceived benefits of actions are critical to the development of interventions to improve adherence to recommendations.